The MFDS said Janssen COVID-19 vaccine should not be vaccinated for people with a history of Systemic Capillary Leak Syndrome (SCLS).

This is in accordance with the European EMA recommendation and is similar to the action that was taken on the AstraZeneca vaccine on the 14th of last month.

The MFDS released the Dear Healthcare Professional Letter on the 12th.

EMA's PRAC announced that Systemic Capillary Leak Syndrome should be added as a new side effect of the Janssen vaccine. It reviewed three cases of Systemic Capillary Leak Syndrome in Janssen COVID-19 vaccine recipients, one with a history of Systemic Capillary Leak Syndrome and two with fatalities.

Syst